Lian Brian (CIK 1614578) reported 12 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-29). Recent activity: Buy VKTX (221,667 shares), Sell VKTX (148,517 shares), Buy VKTX (78,400 shares), Buy VKTX (224,080 shares), Sell VKTX (132,454 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-29 | Viking Therapeutics, Inc. (VKTX) | President & CEO | Buy | 221,667 | $0 |
| 2026-07-29 | Viking Therapeutics, Inc. (VKTX) | President & CEO | Sell | 148,517 | $4.9M |
| 2026-01-05 | Viking Therapeutics, Inc. (VKTX) | President & CEO | Buy | 78,400 | $0 |
| 2026-01-05 | Viking Therapeutics, Inc. (VKTX) | President & CEO | Buy | 224,080 | $0 |
| 2026-01-05 | Viking Therapeutics, Inc. (VKTX) | President & CEO | Sell | 132,454 | $4.3M |
| 2026-01-05 | Viking Therapeutics, Inc. (VKTX) | President & CEO | Sell | 53,279 | $1.8M |
| 2026-01-05 | Viking Therapeutics, Inc. (VKTX) | President & CEO | Sell | 41,276 | $1.4M |
| 2026-01-05 | Viking Therapeutics, Inc. (VKTX) | President & CEO | Sell | 6,400 | $224,448 |
| 2025-10-28 | Viking Therapeutics, Inc. (VKTX) | President & CEO | Buy | 70,084 | $0 |
| 2025-10-28 | Viking Therapeutics, Inc. (VKTX) | President & CEO | Sell | 38,989 | $1.4M |
| 2025-07-03 | Viking Therapeutics, Inc. (VKTX) | President & CEO | Buy | 48,333 | $0 |
| 2025-07-03 | Viking Therapeutics, Inc. (VKTX) | President & CEO | Sell | 26,889 | $747,514 |
Source: SEC Form 4 filings · as of 2026-07-29